Get to know our clinical trials
Breast cancer Response EValuation for Individualized TherapY (BREVITY) clinical trial.
THE AIM OF THE PRESENT STUDY IS TO ESTABLISH CUT-OFF POINTS BETWEEN RDA RESPONSE ZONES AND TO VALIDATE THE PERFORMANCE CHARACTERISTICS OF THE ASSAY IN TERMS OF ABILITY TO PREDICT RESPONSE DURING NEOADJUVANT CHEMOTHERAPY.
Technical Summary
- Code EudraCT: .
- Protocol number: RnaDx-BRV-BC-01
- Link to Clinical Trials
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
More information about this clinical trial
Information offered by the Spanish Registry of Clinical Studies
- Summary
- Information
- Calendar
- Headquarters
- Drugs
Do you want to participate in this trial?
Request an appointment for our specialists to assess whether you qualify for this clinical trial
Do you prefer to send us your reports?
If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.